Credit Suisse’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,833
Closed -$13K 4230
2018
Q4
$13K Sell
1,833
-1,292
-41% -$14.4K ﹤0.01% 3847
2018
Q3
$60K Sell
3,125
-2,351
-43% -$83.9K ﹤0.01% 3738
2018
Q2
$310K Sell
5,476
-468
-8% -$23.7K ﹤0.01% 3620
2018
Q1
$251K Buy
5,944
+1,835
+45% +$78.8K ﹤0.01% 3635
2017
Q4
$220K Sell
4,109
-4,387
-52% -$232K ﹤0.01% 3720
2017
Q3
$379K Buy
8,496
+4,112
+94% +$187K ﹤0.01% 3631
2017
Q2
$213K Sell
4,384
-723
-14% -$42.6K ﹤0.01% 3605
2017
Q1
$370K Sell
5,107
-19,862
-80% -$1.31M ﹤0.01% 3445
2016
Q4
$1.43M Buy
24,969
+18,455
+283% +$1.69M ﹤0.01% 2713
2016
Q3
$834K Sell
6,514
-4,021
-38% -$515K ﹤0.01% 3102
2016
Q2
$1.31M Buy
10,535
+4,295
+69% +$494K ﹤0.01% 2688
2016
Q1
$522K Buy
6,240
+1,841
+42% +$152K ﹤0.01% 3209
2015
Q4
$435K Buy
4,399
+482
+12% +$51.7K ﹤0.01% 3486
2015
Q3
$480K Sell
3,917
-2,028
-34% -$275K ﹤0.01% 3424
2015
Q2
$911K Buy
5,945
+2,128
+56% +$351K ﹤0.01% 3271
2015
Q1
$652K Sell
3,817
-54
-1% -$8.18K ﹤0.01% 3346
2014
Q4
$591K Sell
3,871
-6,376
-62% -$796K ﹤0.01% 3578
2014
Q3
$1.09M Buy
10,247
+1,884
+23% +$263K ﹤0.01% 2976
2014
Q2
$1.27M Sell
8,363
-5,955
-42% -$792K ﹤0.01% 3077
2014
Q1
$1.84M Buy
14,318
+9,513
+198% +$1.48M ﹤0.01% 2577
2013
Q4
$838K Buy
4,805
+2,484
+107% +$427K ﹤0.01% 3414
2013
Q3
$375K Sell
2,321
-7,346
-76% -$1.16M ﹤0.01% 3655
2013
Q2
$1.28M Buy
+9,667
New +$1.36M ﹤0.01% 2608

Other funds holding ELGX

Credit Suisse's ELGX Position: Q1 2019 in Review

Credit Suisse sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 1,833 shares — an estimated $13K sold.

Credit Suisse first reported a position in ELGX in Q2 2013 and held it in 23 quarters. The position peaked at $1.84M in Q1 2014. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Credit Suisse reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Credit Suisse sold 1,833 Endologix Inc shares in Q1 2019, an estimated $13K.
  • Credit Suisse first reported a position in Endologix Inc in Q2 2013 and held it in 23 quarters.
  • Credit Suisse's Endologix Inc position peaked at $1.84M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.